| (11) | Registration Number: | P20250206 (Validated european patent) | |
| (21) | File number: | P20250206T |
| (22) | Date of filing the request: | 18.02.2025 |
| (45) | Patent Publication Date and Gazette Number: | 11.04.2025 |
| (54) | English Title: | 3-SULFOPROPANOIC ACID FOR TREATING NEURODEGENERATIVE DISORDERS |
| (96) | Number of the European patent application: | EP 19752795.5, 30.07.2019 | |
| (97) | Publication data of the European patent application: | EP 3829563, 09.06.2021, 202123, en | |
| (97) | Publication data of the European patent: | EP 3829563, 20.11.2024, 202447, en | |
| (51) | IPC: | A61K 31/185 (2006.01) |
| | | A61K 31/19 (2006.01) |
| | | A61P 25/28 (2006.01) |
| (73) | Holder(s): | | 1. | Alzheon, Inc., 111 Speen Street, Framingham, MA 01701, US |
| |
| (72) | Inventor(s): | | 1. | John Hey, Framingham, MA 01701, US |
| |
| | | 2. | Petr Kocis, Framingham, MA 01701, US |
| |
| | | 3. | Martin Tolar, Framingham, MA 01701, US |
| |
| | | 4. | Neil William Flanzraich, Coral Gables, FL 33143, US |
| |
| (74) | Representative: | Odvjetnik Tomislav Hadžija, u suradnji sa DENNEMEYER & ASSOCIATES,
BCI- Business Center International - 1. kat, Miramarska cesta 24, 10000 Zagreb, HR
|
| (30) | Priority Data: | | (31) | 201862713061 P | | (32) | 01.08.2018 | | (33) | US |
|
| (86) | PCT Application Number and Date | PCT/US2019044023; 30.07.2019 |
| (87) | PCT Publication Number and Date | WO2020028290; 06.02.2020 |
| (46) | Publication Date of Translation of a European Patent Claims and the Gazette Number: | 11.04.2025 |
| | Annual fee: | 16.07.2026 for the 8th year | |
|
| |